PHAT — Phathom Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $567.12m
- $934.14m
- $175.11m
Phathom Pharmaceuticals Inc expected to post a loss of $1.04 a share - Earnings Preview
Brief: Phathom Pharmaceuticals To Report Second Quarter 2025 Financial Results And Provide Business Update On Thursday, August 7, 2025
Brief: Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-WEC Energy, FuelCell Energy, Phathom Pharma
Brief: Phathom Pharmaceuticals Says FDA Approves Co's Petition For 10 Years Exclusivity For Voquezna
Phathom Pharma soars after FDA grants 10-year exclusivity shield for stomach drug
Phathom Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Phathom Pharmaceuticals Q1 Net Income USD -94.316 Million
Phathom Pharmaceuticals Inc expected to post a loss of $1.15 a share - Earnings Preview
Brief: Phathom Pharmaceuticals To Report First Quarter 2025 Financial Results And Provide Business Update On Thursday, May 1, 2025
Brief: Phathom Pharmaceuticals Appoints Ted Schroeder To Its Board Of Directors
Brief: Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Phathom Pharmaceuticals Announces Leadership Succession
Phathom Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Phathom Pharmaceuticals Submits Citizen Petition To FDA
Phathom Pharmaceuticals Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: Phathom Pharmaceuticals Q3 Net Income USD -85.577 Million
Brief: Phathom Pharmaceuticals To Report Third Quarter 2024 Financial Results And Provide Business Update On Thursday, November 7, 2024
Brief: Phathom Pharmaceuticals Announces Pricing of $130 Million Offering of Common Stock and Pre-Funded Warrants